SEC 13F Intelligence

Loews Corp / ABBV

Loews Corp’s Abbvie Inc Position

Does Loews Corp own Abbvie Inc (ABBV)? Not currently — the last reported position was 80.0K shares worth $13M in Q4 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$13M
Q4 2022
Shares
80.0K
% of Portfolio
+0.12%
Quarters Held
12
position exited

Position History ABBV

Reported value by quarter
Q1 ’20: $11MQ1 ’20Q2 ’20: $13MQ3 ’20: $11MQ3 ’20Q4 ’20: $21MQ1 ’21: $19MQ1 ’21Q2 ’21: $18MQ3 ’21: $22MQ3 ’21Q4 ’21: $23MQ1 ’22: $13MQ1 ’22Q2 ’22: $12MQ3 ’22: $9MQ3 ’22Q4 ’22: $13Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 202280.0K$13M+0.12%
Q3 202270.0K$9M+0.10%
Q2 202280.0K$12M+0.11%
Q1 202280.0K$13M+0.11%
Q4 2021170.0K$23M+0.20%
Q3 2021200.0K$22M+0.20%
Q2 2021160.0K$18M+0.15%
Q1 2021180.0K$19M+0.17%
Q4 2020195.0K$21M+0.21%
Q3 2020125.0K$11M+0.14%
Q2 2020135.0K$13M+0.16%
Q1 2020150.0K$11M+0.14%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Loews Corp’s full portfolio or all institutional holders of ABBV.